Aevis Victoria EBIT per Share
The EBIT per Share of Aevis Victoria (AEVS.SW) as of Aug 12, 2026 is -0.61 CHF. In the previous year, EBIT per Share was 0.38 CHF — a change of -257.78% (lower).
Get this data via API
Financial Data API
EBIT per Share
-0.61CHF
YoY
-257.78%
Last updated:
EBIT per Share of Aevis Victoria is 2026 -0.61 CHF. EBIT per Share of Aevis Victoria was 2025 0.38 CHF. It decreases by -257.78% lower compared to the previous year.
Access this data via the Eulerpool API
Aevis Victoria Stock analysis
What does Aevis Victoria do? Aevis Victoria SA is a Swiss company headquartered in Geneva. It was founded in 2006 and has developed a wide range of services over the years through strategic decisions and acquisitions.
The history of Aevis Victoria began with the acquisition of three private clinics by founder Antoine Hubert. In 2007, the company started working on its first project, the Genolier Swiss Medical Network, a network of private clinics in Switzerland and France. Aevis Victoria has since made several other acquisitions, including a majority stake in Victoria-Jungfrau Collection AG, a renowned hotel group in Switzerland.
Aevis Victoria's business model is based on investing in companies operating in the fields of healthcare, wellness, and lifestyle. The company offers a wide range of services including private clinics, spa and wellness centers, hotel and property management, and innovative technology and software for the healthcare and tourism industries.
Among Aevis Victoria's various divisions, the Genolier Swiss Medical Network is the centerpiece. The network's clinics offer a comprehensive range of services including general medicine, surgery, obstetrics and gynecology, cardiology, neurology, and oncology. The network specializes in treating international patients and is globally recognized for its high quality medical care and sophisticated infrastructure.
Aevis Victoria is also active in the field of spa and wellness centers. The group owns and operates several luxury wellness resorts, including the Victoria Jungfrau Grand Hotel & Spa in Interlaken and the La Réserve Genève Hotel & Spa in Geneva. These properties are equipped to the highest standards and offer a wide range of wellness and spa services tailored to the needs of discerning customers.
In the hotel and property management sector, Aevis Victoria is a major player in the Swiss market and operates several prestigious hotels. In addition to Victoria-Jungfrau Collection AG, the group also owns the Carlton Hotel St. Moritz and the Hotel Royal Savoy Lausanne. When developing and implementing new real estate projects, Aevis Victoria places great importance on sustainability, quality, and innovation.
Aevis Victoria also invests in innovative technologies and software for the healthcare and tourism industries. The company has previously financed several start-ups involved in the development of medical devices and digital platforms for the healthcare sector. The focus is on improving medical care and the patient experience.
In summary, Aevis Victoria is a significant Swiss company in the field of healthcare, wellness, and lifestyle. The company's wide range of services, closely linked to its vision of high quality and innovation, is exemplary. Aevis Victoria will continue to invest in new technologies and services to expand its offerings and strengthen its position in these growing markets. Aevis Victoria is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Aevis Victoria stock
EBIT per Share of Aevis Victoria is -0.61 CHF in 2026.
EBIT per Share of Aevis Victoria changed from 0.38 CHF to -0.61 CHF, representing a -257.78% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Aevis Victoria since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Aevis Victoria
All Key Metrics — Aevis Victoria
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth